| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0001 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0002 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.15 | 0.0002 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0002 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0002 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0003 |
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0005 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0006 |